Gli inibitori del recettore IIb/IIIa - Cuorediverona.it
Gli inibitori del recettore IIb/IIIa - Cuorediverona.it Gli inibitori del recettore IIb/IIIa - Cuorediverona.it
Study design Inclusion Criteria: STEMI all comers: shock, elderly included Exclusion Criteria: Contraindications to Gp IIb/IIIa Tirofiban SHDB Cypher STEMI UFH - ASA Clopidogrel Abciximab stand. regimen BMS CCU Cath-Lab Valgimigli et al. Cardiovasc Drugs Ther 04; 18: 225-30 Università degli Studi di Ferrara - Cattedra di Cardiologia
% 50 45 40 35 30 25 20 15 10 5 P=0.043 0 8-Month Outcome n=175 Abciximab+BMS P=0.004 Tirofiban+SES P=0.01 P=0.8 P=0.6 P>0.99 P=0.005 50% 9% 19% MACE Death MI TVR CVA BR 1° EndPoint Valgimigli et al. JAMA 2005; 293: 2109-117 36% Università degli Studi di Ferrara - Cattedra di Cardiologia
- Page 5 and 6: GP IIb-IIIa Inhibitors costituiscon
- Page 8 and 9: Cardiologia “De Gasperis”- Nigu
- Page 10 and 11: Inibitori GPIIb/IIIa Artist’s con
- Page 12: Characteristics of GP IIb/IIIa Inhi
- Page 15 and 16: Patogenesi delle Sindromi Coronaric
- Page 17 and 18: Sindromi Coronariche Acute ST-segme
- Page 19: 8 16 Lancet 1997; 349:1429-35 35
- Page 22 and 23: UA/NSTEMI Beneficio solo se PCI
- Page 24 and 25: % of Patients IIb/IIIa Inhibition w
- Page 26 and 27: GP IIb/IIIa Inhibitor During Medica
- Page 28 and 29: Peterson E.D.et al.: Early use of g
- Page 30 and 31: ISAR-COOL study - Pre-procedural ou
- Page 32 and 33: CAPTURE Results by Troponin T Statu
- Page 34 and 35: GP IIb/IIIa Inhibition in Diabetics
- Page 36 and 37: Gli inibitori GP IIb/IIIa IIIa ridu
- Page 38 and 39: ESC PCI guidelines 2004 2004 Recomm
- Page 40 and 41: SCA: UA/NSTEMI L’applicazione del
- Page 42 and 43: Coronarografia in base a età e TIM
- Page 44 and 45: Sindromi Coronariche Acute ST-segme
- Page 46 and 47: Occlusive thrombus contains Fibrin
- Page 48 and 49: Abciximab Improves ST Res-90 min ST
- Page 50 and 51: RAPPORT, ISAR 2, ADMIRAL, CADILLAC
- Page 52 and 53: 5 GPIIb/IIIa inhibitors trials in P
- Page 54 and 55: BMS and abciximab display a synergi
- Page 58 and 59: Multi-STRATEGY MULTIcenter evaluati
- Page 60 and 61: GUSTO V AMI GUSTO V - Trial Schemat
- Page 62 and 63: IIb/IIIa Varie...ed eventuali
- Page 64 and 65: IIb/IIIa e PCI: Nei pazienti stabil
- Page 66: Conclusioni Glycoprotein IIb/IIIa I
Study design<br />
Inclusion Cr<strong>it</strong>eria: STEMI all comers: shock, elderly included<br />
Exclusion Cr<strong>it</strong>eria: Contraindications to Gp <strong>IIb</strong>/<strong>IIIa</strong><br />
Tirofiban SHDB<br />
Cypher<br />
STEMI<br />
UFH - ASA<br />
Clopidogrel<br />
Abciximab<br />
stand. regimen<br />
BMS<br />
CCU<br />
Cath-Lab<br />
Valgimigli et al. Cardiovasc Drugs Ther 04; 18: 225-30<br />
Univers<strong>it</strong>à degli Studi di Ferrara - Cattedra di Cardiologia
Change language